Exane Derivatives’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$269 Sell
3
-461
-99% -$41.3K ﹤0.01% 646
2022
Q1
$51.5K Hold
464
0.01% 564
2021
Q4
$48K Sell
464
-1,180
-72% -$122K 0.01% 495
2021
Q3
$206K Buy
1,644
+909
+124% +$114K 0.05% 376
2021
Q2
$93.6K Sell
735
-5,480
-88% -$698K 0.02% 534
2021
Q1
$734K Sell
6,215
-804
-11% -$95K 0.21% 102
2020
Q4
$822K Buy
7,019
+1,293
+23% +$151K 0.24% 100
2020
Q3
$595K Buy
5,726
+707
+14% +$73.5K 0.17% 108
2020
Q2
$460K Buy
5,019
+5,010
+55,667% +$459K 0.12% 134
2020
Q1
$812 Sell
9
-147
-94% -$13.3K ﹤0.01% 529
2019
Q4
$18.3K Sell
156
-7,098
-98% -$833K ﹤0.01% 382
2019
Q3
$788K Buy
7,254
+5,926
+446% +$644K 0.14% 114
2019
Q2
$129K Buy
1,328
+1,019
+330% +$99.2K 0.02% 285
2019
Q1
$28.1K Sell
309
-125
-29% -$11.4K 0.01% 344
2018
Q4
$39.5K Hold
434
0.01% 351
2018
Q3
$42.8K Sell
434
-147
-25% -$14.5K 0.01% 353
2018
Q2
$50.2K Sell
581
-643
-53% -$55.5K 0.01% 356
2018
Q1
$95.9K Buy
1,224
+382
+45% +$29.9K 0.02% 289
2017
Q4
$68K Buy
+842
New +$68K 0.01% 291
2016
Q4
Sell
-1,058
Closed -$91.4K 614
2016
Q3
$91.4K Buy
+1,058
New +$91.4K 0.01% 221
2016
Q2
Sell
-515
Closed -$38.6K 578
2016
Q1
$38.6K Sell
515
-707
-58% -$53K 0.01% 298
2015
Q4
$94K Sell
1,222
-3,487
-74% -$268K 0.01% 190
2015
Q3
$315K Buy
4,709
+816
+21% +$54.6K 0.04% 136
2015
Q2
$288K Hold
3,893
0.03% 163
2015
Q1
$304K Buy
3,893
+1,690
+77% +$132K 0.03% 153
2014
Q4
$159K Buy
+2,203
New +$159K 0.02% 216